Pelitinib ≥95%

Supplier: ADIPOGEN CORP MS
Warning

Synonyms: (E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, (E)-N-(4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, EKB 569, Pelitinib, (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-dimethylamino-2-butenamide

SYN-1141-M001 SYN-1141-M005 SYN-1141-M010 SYN-1141-M050
102992-320EA 119.08 USD
102992-320 102992-322 102992-324 102992-326
Pelitinib ≥95%
Pelitinib (EKB-569)

Pelitinib, also known as EKB 569, is a potent, irreversible inhibitor of the EGFR tyrosine kinase. Cell based IC(50) values range from 39nM to 80nM and in vitro kinase assays are in sub-nanomolar range for EGFR receptors. In xenograft tumor models using overexpressing A431 cells Pelitinib inhibits growth of tumors with effective doses of 3.5-10mg/kg/dl. Recent research also shows that Pelitinib can potentiate radiation induced killing of squamouse cell carcinoma via the inhibition of IR-induced NF-kappaB mediated cell survial pathway.

Formula: C₂₄H₂₃ClFN₅O₂
MW: 467.92 g/mol
Storage Temperature: Freezer
MDL Number: MFCD09837868
CAS Number: 257933-82-7

Order Now

Specification Test Results

Purity 95%
Appearance/Color Solid.
Solubility Soluble in DMSO or ethanol.

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR